The U.S. Food and Drug Administration has given 510k approval to Filligent for its BioFriend BioMask (series A) anti-viral surgical facemask, according to a company news release.
Read the full report in Becker’s Hospital Review on Filligent’s BioFriend BioMask.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
